Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

BHYP vs CLNK: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

BHYP Wins Head-to-Head Institutional Verdict (0–0 across 6 Pillars · 2–1 Matrix Metrics)

BHYP Overall Winner 6-Pillar Tally: BHYP 0 – 0 CLNK (6 Tie) Matrix Metrics: BHYP 2 – 1 CLNK

As of Nov 16, 2026, BHYP (BHYP) is the stronger overall head-to-head candidate over CLNK (CLNK) in the Tradestie Institutional Equity Comparison Engine, winning 2–1 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). BHYP carries a Unified Composite Score of 53.5/100 (HOLD) at $38.51 (N/M Forward P/E, N/A operating margin), whereas CLNK carries 43.7/100 (HOLD) at $16.64 (N/M Forward P/E, N/A operating margin).

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About BHYP vs CLNK
BHYP US Equity Head-to-Head Winner
BHYP
Institutional Equity
$38.51
-5.89% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 2.21β · 79% Vol
Unified Composite Score
53.5 / 100 HOLD
Tech 36.0 Fund 51.0 Flow 50.0 Mom 60.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 36
RSI-14: 35.8 · SMA20: $44.57 · SMA50: $46.78
CLNK US Equity
CLNK
Institutional Equity
$16.64
-7.98% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 1.71β · 58% Vol
Unified Composite Score
43.7 / 100 HOLD
Tech 25.0 Fund 50.0 Flow 50.0 Mom 55.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 29
RSI-14: 28.7 · SMA20: $20.14 · SMA50: $22.05

6-Pillar Scorecard Institutional Category Breakdown (BHYP 0 – 0 CLNK)

Columns: Metric · BHYP · CLNK
1. Valuation Multiples Tie
Forward P/E N/M N/M
Trailing P/E N/M N/M
PEG Ratio N/M N/M
EV / Revenue N/M N/M
2. Growth & Scale Tie
Revenue Growth (YoY) N/A N/A
Earnings Growth (YoY) N/A N/A
TTM Revenue (USD) N/A N/A
Market Cap N/A N/A
3. Profitability & Quality Tie
Gross Margin N/A N/A
Operating Margin N/A N/A
Net Profit Margin N/A N/A
Return on Equity (ROE) N/A N/A
4. Balance Sheet & Cash Flow Tie
Cash Generation (TTM) N/A N/A
Cash Flow Margin N/A N/A
Net Cash / Leverage N/A ROE N/A ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Neutral NEUTRAL · Neutral
6. R&D & Supply-Chain Moat Tie
OpEx & R&D Intensity N/A N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Institutional Equity Operator Institutional Equity Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: BHYP (2) vs CLNK (1)
Institutional Metric BHYP CLNK Criterion Row Edge
Market Capitalization
Scale
N/A N/A Larger Scale Tie
Trailing P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
N/A N/A Higher Growth Tie
Operating Margin (TTM)
Profitability
N/A N/A Higher Margin Tie
Net Profit Margin
Profitability
N/A N/A Higher Margin Tie
Return on Equity (ROE)
Capital Efficiency
N/A N/A Higher ROE Tie
52-Week Range Position
Momentum
47% ($24–$55) 25% ($13–$28) Stronger Trend BHYP
Beta / 30D Volatility
Risk Regime
2.21β · 79% Vol 1.71β · 58% Vol Lower Realized Risk CLNK
Unified Institutional Score
Composite Signal
53.5 / 100 (HOLD) 43.7 / 100 (HOLD) Higher Composite BHYP
Trailing 12M Revenue (USD)
Operating Scale
N/A N/A FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
N/A N/A Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A (N/A ROE) N/A (N/A ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon BHYP +11.87 pp
BHYP: -13.48% · CLNK: -25.35%
3M Horizon BHYP +20.06 pp
BHYP: +16.38% · CLNK: -3.68%
6M Horizon BHYP +51.57 pp
BHYP: +47.87% · CLNK: -3.7%
1Y Horizon BHYP +63.21 pp
BHYP: +53.92% · CLNK: -9.29%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on BHYP vs CLNK. Trailing 12-month operating profitability (BHYP N/A vs CLNK N/A) and valuation multiples (BHYP N/M vs CLNK N/M Forward P/E) are benchmarked directly in Pillar 4 below.

BHYP ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M
CLNK ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
BHYP UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact BHYP Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
CLNK UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact CLNK Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
BHYP Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
CLNK Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ BHYP vs CLNK Key Questions & Quantitative Answers

As of Nov 16, 2026, BHYP (BHYP) is the stronger overall head-to-head candidate over CLNK (CLNK) in the Tradestie Institutional Equity Comparison Engine, winning 2–1 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). BHYP carries a Unified Composite Score of 53.5/100 (HOLD) at $38.51 (N/M Forward P/E, N/A operating margin), whereas CLNK carries 43.7/100 (HOLD) at $16.64 (N/M Forward P/E, N/A operating margin). Technically, BHYP sits in a Neutral phase (RSI 35.8, UNCLASSIFIED options structure) and CLNK sits in a Neutral phase (RSI 28.7, UNCLASSIFIED options structure).

BHYP and CLNK split Growth & Scale metrics: BHYP posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with CLNK at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, BHYP generates N/A in USD-normalized revenue versus N/A for CLNK. In operating R&D and SG&A reinvestment, BHYP deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for CLNK.

BHYP and CLNK trade at balanced relative valuation multiples. BHYP trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas CLNK trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against BHYP (N/A ROE) versus CLNK (N/A ROE) capital efficiency.

In options market volatility and institutional positioning, BHYP carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (2.21β · 79% Vol realized risk). By comparison, CLNK carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.71β · 58% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.